
1y2 min read
Medical Article
Small cell lung cancer (SCLC) is an aggressive and often rapidly progressing form of lung cancer, representing a significant challenge in oncology. Extensive-stage SCLC, where the cancer has spread beyond the confines of the lung, is associated with a particularly poor prognosis. While the standard of care for extensive-stage SCLC has historically

Comparison of Atezolizumab, Durvalumab, Pembrolizumab, and Nivolumab as First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer
399 Reached
Similar Content

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Black Lesion in Old Female
1970 Reached5 Comments11 Likes

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes

Management of Metastatic Prostate Cancer
1037 Reached5 Comments2 Likes